Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A high-throughput response to the SARS-CoV-2 pandemic

SLAS DISCOVERY(2024)10.1016/j.slasd.2024.100160Source: DataRank Database

A high-throughput response to the SARS-CoV-2 pandemic is a research paper published in SLAS DISCOVERY (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access3 citations

Download PDF

Cite:

Linked data & code

gen

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.88)OA: goldTopics (41)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

S K Sanders,Melinda Sosa ORCID,Sara McKellip,N. Miranda Nebane ORCID,Yohanka Martinez-Gzegozewska ORCID

Live enrichment

PubMed:38761981 PMC:PMC12182970 OpenAlex:https://openalex.org/W4396965928

NIAID NIH HHS

Grant: G20 AI167409

NIAID NIH HHS

Grant: UC6 AI058599

NIAID NIH HHS

Grant: U19 AI142759

NIAID NIH HHS

Grant: UC7 AI180255

National Institute of Allergy and Infectious Diseases

National Institutes of Health

FWCI

0.88

Citation Percentile

0.7%

Citation Trend

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.slasd.2024.100160

GOLDhttps://doi.org/10.1016/j.slasd.2024.100160

publisherhttps://doi.org/10.1016/j.slasd.2024.100160

publisherhttps://api.elsevier.com/content/article/PII:S2472555224000224?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2472555224000224?httpAccept=text/plain

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testingMedicineHumansCOVID-19SARS-CoV-2High-Throughput Screening AssaysPandemicsAntiviral Agents

MeSH Terms

COVID-19SARS-CoV-2Antiviral AgentsHumansHigh-Throughput Screening AssaysPandemics

Keywords

PandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Throughput2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)VirologyComputer scienceMedicineOutbreakTelecommunicationsInfectious disease (medical specialty)DiseaseAntiviralSARS-CovCoronavirusSARSHTSdrug discoveryHigh-throughputMersBsl-3Sars2Covid-19Sars-cov-2Covid

Sustainable Development Goals

SDG 0: Good health and well-being

A high-throughput response to the SARS-CoV-2 pandemic

FAIR Checklist

Authors (15)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)